David Berry

Director at Omega Therapeutics

David Berry joined Flagship Pioneering in 2005 where he is a general partner, focusing on conceiving, creating, resourcing, and launching groundbreaking companies. Dr. Berry has co-founded more than 20 companies across life sciences and sustainability, including Joule, Seres Therapeutics (NASDAQ: MCRB), T2 Biosystems (NASDAQ: TTOO), Indigo Agriculture, Evelo Biosciences, Eleven Biotherapeutics (NASDAQ: EBIO), LS9 (acquired by Renewable Energy Group), Axcella Health and Inari Agriculture. He has served as founding CEO of more than 10 companies, including Seres, Evelo and Axcella.

Dr. Berry received his M.D. from Harvard Medical School and his Ph.D. from MIT in biological engineering.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Omega Therapeutics

3 followers

Omega Therapeutics is a privately held, development-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine.


Industries

Employees

51-200

Links